Yuhua Li

4.2k total citations
148 papers, 3.1k citations indexed

About

Yuhua Li is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yuhua Li has authored 148 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 41 papers in Oncology and 37 papers in Molecular Biology. Recurrent topics in Yuhua Li's work include Immune Cell Function and Interaction (21 papers), CAR-T cell therapy research (21 papers) and Immunotherapy and Immune Responses (18 papers). Yuhua Li is often cited by papers focused on Immune Cell Function and Interaction (21 papers), CAR-T cell therapy research (21 papers) and Immunotherapy and Immune Responses (18 papers). Yuhua Li collaborates with scholars based in China, United States and Taiwan. Yuhua Li's co-authors include Yanjie He, Ke Huang, Hyunsuk Shim, Zhongxing Liang, Cheng Zhu, Xiaoling Xie, Qibing Mei, Yuxing Hu, Yazhuo Wang and Shengkang Huang and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Yuhua Li

140 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuhua Li China 31 1.3k 757 739 518 334 148 3.1k
Antoine Dufour Canada 29 1.4k 1.1× 982 1.3× 567 0.8× 1.1k 2.1× 110 0.3× 115 3.3k
Roberto R. Rosato United States 32 2.3k 1.8× 665 0.9× 314 0.4× 350 0.7× 168 0.5× 61 3.3k
Yongliang Zhang Singapore 31 1.9k 1.4× 782 1.0× 1.3k 1.8× 321 0.6× 170 0.5× 87 3.5k
Nataša Obermajer Slovenia 35 1.3k 1.0× 960 1.3× 1.9k 2.5× 596 1.2× 311 0.9× 73 4.1k
Chunyan Liu China 32 1.2k 0.9× 787 1.0× 1.4k 1.9× 386 0.7× 133 0.4× 183 3.6k
Roni Nowarski Israel 14 2.1k 1.6× 899 1.2× 1.1k 1.4× 405 0.8× 383 1.1× 17 3.7k
Nathalie Heuzé‐Vourc'h France 31 896 0.7× 644 0.9× 692 0.9× 345 0.7× 193 0.6× 94 2.9k
Hong Zheng China 28 1.4k 1.1× 564 0.7× 602 0.8× 430 0.8× 106 0.3× 178 3.0k
Sophie Viaud France 21 2.0k 1.6× 992 1.3× 1.6k 2.2× 721 1.4× 247 0.7× 29 3.6k
Mohammad Hossein Modarressi Iran 36 2.3k 1.7× 500 0.7× 533 0.7× 578 1.1× 84 0.3× 202 3.7k

Countries citing papers authored by Yuhua Li

Since Specialization
Citations

This map shows the geographic impact of Yuhua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhua Li more than expected).

Fields of papers citing papers by Yuhua Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhua Li. The network helps show where Yuhua Li may publish in the future.

Co-authorship network of co-authors of Yuhua Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhua Li. A scholar is included among the top collaborators of Yuhua Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhua Li. Yuhua Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jianyu, Rong Hu, Honghao Zhang, et al.. (2025). Administration of lipid nanoparticle-encapsulated mRNA encoding CCR7, CXCL16 and GITRL effectively mobilizes antitumor T cell immunity. International Journal of Biological Macromolecules. 318(Pt 1). 144766–144766.
2.
Fu, Xinhui, Jinglin Huang, Xinjuan Fan, et al.. (2024). Prognosis and immunotherapy efficacy in dMMR&MSS colorectal cancer patients and an MSI status predicting model. International Journal of Cancer. 155(4). 766–775. 5 indexed citations
3.
4.
Wu, Xinzhou, Zhouguang Jiao, Junying Zhang, Feng Li, & Yuhua Li. (2023). Expression of TFRC helps to improve the antineoplastic effect of Ara-C on AML cells through a targeted delivery carrier. Journal of Nanobiotechnology. 21(1). 126–126. 3 indexed citations
5.
Zhang, Wei, Yuhua Li, Jingqi Zhou, et al.. (2023). Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients. Frontiers in Endocrinology. 14. 1278505–1278505. 11 indexed citations
6.
Zhao, Liang, Xuan Zhou, Jilong Yang, et al.. (2023). Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion. Human Cell. 36(5). 1716–1728. 3 indexed citations
7.
Xie, Xiaoling, Yuxing Hu, Tong Ye, et al.. (2021). Author Correction: Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nature Biomedical Engineering. 5(5). 482–482. 1 indexed citations
8.
Wang, Changlong, Wei Zhang, Yanjie He, et al.. (2021). Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects. Nature Nanotechnology. 16(12). 1413–1423. 76 indexed citations
9.
Xiao, Xinyi, Shengkang Huang, Sifei Chen, et al.. (2021). Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies. Journal of Experimental & Clinical Cancer Research. 40(1). 367–367. 167 indexed citations
10.
Wen, Jinhua, Ying Zhou, & Yuhua Li. (2020). PXR–ABC drug transporters/CYP‐mediated ursolic acid transport and metabolism in vitro and vivo. Archiv der Pharmazie. 353(9). e2000082–e2000082. 19 indexed citations
11.
Zhou, Xuan, Sanfang Tu, Chunsheng Wang, et al.. (2020). Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas. Frontiers in Immunology. 11. 564099–564099. 41 indexed citations
12.
Xie, Xiaoling, et al.. (2019). Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma. Molecular Cancer Therapeutics. 18(12). 2258–2269. 6 indexed citations
13.
Liu, Xuejian, et al.. (2017). Combinational effect of pulsed dye laser and propranolol on treatment of superficial hemangioma. Biomedical Research-tokyo. 28(20). 8951–8953. 2 indexed citations
14.
Huang, Rui, Yoshihiro Hayashi, Xiaomei Yan, et al.. (2017). HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis. Haematologica. 102(11). 1956–1968. 9 indexed citations
15.
Wang, Linli, Qun Shen, Qianyu Chen, et al.. (2016). Optimized Approaches for Generation of Integration-free iPSCs from Human Urine-Derived Cells with Small Molecules and Autologous Feeder. Stem Cell Reports. 6(5). 717–728. 36 indexed citations
16.
Wang, Lei, et al.. (2013). Real-Time Quantitative Polymerase Chain Reaction Assay for Detecting the Eps8 Gene in Acute Myeloid Leukemia. Clinical Laboratory. 59(11+12/2013). 1261–9. 5 indexed citations
17.
R, Li, et al.. (2013). Generation and characterization of a polyclonal antibody against human high mobility group box 4. Molecular Medicine Reports. 8(5). 1460–1464. 1 indexed citations
18.
Wang, Zhipeng, Meng Fu, Lifeng Wang, et al.. (2013). p21-Activated Kinase 1 (PAK1) Can Promote ERK Activation in a Kinase-independent Manner. Journal of Biological Chemistry. 288(27). 20093–20099. 61 indexed citations
19.
Liang, Zhongxing, Hui Wu, James Xia, et al.. (2009). Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochemical Pharmacology. 79(6). 817–824. 276 indexed citations
20.
Wang, Weiqun, Yuhua Li, Yang Li, et al.. (2008). NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. International Journal of Cancer. 124(3). 521–530. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine Dufour Breakdown of academic impact, for papers by Roberto R. Rosato Breakdown of academic impact, for papers by Yongliang Zhang Breakdown of academic impact, for papers by Nataša Obermajer Breakdown of academic impact, for papers by Chunyan Liu Breakdown of academic impact, for papers by Roni Nowarski Breakdown of academic impact, for papers by Nathalie Heuzé‐Vourc'h Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Sophie Viaud Breakdown of academic impact, for papers by Mohammad Hossein Modarressi
Rankless by CCL
2026